MedPath

信立泰(苏州)药业有限公司

Ownership
-
Established
2010-09-20
Employees
-
Market Cap
-
Website
https://www.salubris.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Teriparatide Injection

Product Name
特立帕肽注射液
Approval Number
国药准字S20220015
Approval Date
Apr 19, 2022
NMPA

Recombinant Teriparatide for Injection

Product Name
欣复泰
Approval Number
国药准字S20190037
Approval Date
Sep 29, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.